Skip to content

A study of the ameliorative effects of allicin in a pre-diabetic population

A study of the ameliorative effects of allicin in a pre-diabetic population

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000831
Enrollment
Unknown
Registered
2025-04-24
Start date
2025-05-12
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pre-diabetes

Interventions

intervention group:Administering oral allicin
control group:Oral administration of placebo capsules of identical appearance

Sponsors

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosed with pre-diabetes; (2) Between 40 and 70 years of age.

Exclusion criteria

Exclusion criteria: (1) Diagnosis of chronic diseases of the gastrointestinal tract that can cause gastrointestinal dysfunction and diseases of malignant tumors (other than non-melanoma skin cancer);(2) Those with unreasonable average daily total energy (female: 3500kcal; male: 4200kca1); (3) Those who are in the pre-diabetic stage and have already been treated with medication; (4)Those who have been diagnosed with diabetes mellitus; (5)Those who are pregnant or lactating or those who have been abusing medications or other substances; (6)Those who are accompanied by speech dysfunction or those who can't communicate properly with their speech; (7)Those with severe visual/auditory verbal communication disorders behavioral and cognitive limitations; (8)Those who do not support this study or who withdraw from the study midway for their own reasons.

Design outcomes

Secondary

MeasureTime frame
Physical Activity Scale;Nutritional Intake Scale;

Primary

MeasureTime frame
Plasma Allicin Concentration;fasting insulin;HbA1c;fasting blood glucose;

Countries

China

Contacts

Public ContactHua Dong

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

dongdong8784@163.com18602229639

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026